Persistent hypercholesterolaemia in frequently relapsing steroid-responsive nephrotic syndrome

Area of Science:

• Pediatric Nephrology
• Clinical Biochemistry

Background:

• Nephrotic syndrome (NS) is a kidney disorder characterized by heavy protein loss in urine.
• Frequently relapsing NS requires long-term management, often involving repeated steroid therapy.
• Hypercholesterolemia is a known complication, but its persistence in pediatric NS requires further investigation.

Purpose of the Study:

• To examine long-term serum cholesterol level changes in children with frequently relapsing steroid-responsive nephrotic syndrome (NS).
• To determine the incidence of hypercholesterolemia during different phases of frequently relapsing NS.

Main Methods:

• Retrospective review of serum cholesterol values in eight pediatric patients with frequently relapsing NS.
• Analysis of cholesterol levels taken just before, during, or immediately after disease relapses.
• Calculation of hypercholesterolemia incidence (serum cholesterol ≥ 200 mg/dL).

Main Results:

• Patients exhibited hypercholesterolemia during clinical remission (mean incidence 81%) and relapse (mean incidence 96%).
• High incidence of steroid therapy was noted preceding relapses (mean 89%).
• Prolonged periods of elevated serum cholesterol were observed even between relapses.

Conclusions:

• Children with frequently relapsing NS experience sustained hypercholesterolemia, persisting even during clinical remission.
• This highlights the need for vigilant monitoring of lipid profiles in these pediatric patients.
• Early and consistent management of hypercholesterolemia may be essential for long-term outcomes in pediatric NS.